ResearcherMassachusetts Institute of TechnologyNo recent work listed
Robin M. Kramer
Matched on OpenAlex author ID A5087463118. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2015: 2 papers · 2016: none · 2017: 1 paper
Papers 3
- In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetic… Co-author DOI 10.1007/s11307-017-1078-6↗
- Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models. First author DOI 10.1016/j.ijrobp.2015.06.001↗
- Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer. Co-author DOI 10.1089/cbr.2015.1869↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- James Russell · 3 shared papers, 2015–2017 · strength 0.20
- Paper Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer. DOI 10.1089/cbr.2015.1869↗
- Paper In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosi… DOI 10.1007/s11307-017-1078-6↗
- Paper Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models. DOI 10.1016/j.ijrobp.2015.06.001↗
- John Laurence Humm · 3 shared papers, 2015–2017 · strength 0.20
- Paper Distribution of Gemcitabine Is Nearly Homogenous in Two Orthotopic Murine Models of Pancreatic Cancer. DOI 10.1089/cbr.2015.1869↗
- Paper In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosi… DOI 10.1007/s11307-017-1078-6↗
- Paper Reverse-Contrast Imaging and Targeted Radiation Therapy of Advanced Pancreatic Cancer Models. DOI 10.1016/j.ijrobp.2015.06.001↗
- Maeve Aine Lowery · 2 shared papers, 2015–2017 · strength 0.12
- Nagavarakishore Pillarsetty · 1 shared paper, 2017 · strength 0.07
- Daniel L.J. Thorek · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.